Clinical Trial Update: A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating ABX-1431 in patients with Tourette syndrome and chronic motor tic disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motor Tic Disorder
• Tourette Syndrome

Drugs mentioned

• ABX-1431 (ABX-1431)

Snippet

Sponsor: Abide Therapeutics | Conditions: Tourette Syndrome, Chronic Motor Tic Disorder | Phase 1 | Status: COMPLETED